Following a steady stream of acquisitions that culminated in three biotech buyouts earlier this year, Gilead Sciences’ CEO has told Fierce how the company’s efforts to expand into oncology and ...
Morgan Stanley kept Gilead at Overweight after its 2026 Global Healthcare Conference. One franchise stood out from everything management discussed.
Groups welcome reversal of Gilead’s price gouging decision that would have resulted in fewer people with HIV getting access to lifesaving treatment. AHF sent a letter signed by over 100 organizations ...
Gilead Sciences has opened its 182,000-square-foot Research Center at its Foster City, California headquarters, expanding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results